Cytecare Hospitals: Financial Breakdown
Decoding financial health metrics of Cytecare Hospitals
Total Revenue₹93.1 Cr18%Prev. FY
Total Expenses₹108.2 Cr7%Prev. FY
Profit After Tax₹-15.1 Cr32%Prev. FY
Total Assets₹70.6 Cr-8%Prev. FY
Net Profit Margin-16.2%42%Prev. FY
FAQs on Financials of Cytecare Hospitals
No. In FY24, Cytecare Hospitals reported a net loss of ₹15.1 Cr, so it was not profitable.
Cytecare Hospitals's revenue grew 18.7% year-on-year, from ₹78.4 Cr in FY23 to ₹93.1 Cr in FY24.
Cytecare Hospitals's estimated EBITDA for FY24 was ₹-5.3 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, Cytecare Hospitals posted revenue of ₹93.1 Cr (up 18.7% YoY) and a net loss of ₹15.1 Cr. Explore the full financials of Cytecare Hospitals here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links